Using brain imaging to personalize electric stimulation for treating anhedonia in bipolar depression
Official title: Developing Brain Imaging Analysis Expertise for Personalizing Transcranial Electric Stimulation in Anhedonia Treatment of Patients With Bipolar Depression
Run by The University of Texas Health Science Center, Houston · NCT05240352 · Data updated 2026-11-12
This study is testing if a type of brain stimulation can help people with bipolar depression who struggle to feel pleasure and see if it makes a difference in their symptoms.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years to 50 Years |
| Sex | All |
| Enrollment | 45 (estimated) |
| Sponsor | The University of Texas Health Science Center, Houston Academic / other |
| Locations | 1 site (Houston, Texas) |
| Status | Recruiting |
| Started | October 6, 2022 |
| Main results expected | December 1, 2026 |
| Study ends | December 1, 2026 |
| Registry record updated | February 18, 2026 |
| Trial ID | NCT05240352 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates include individuals diagnosed with bipolar disorder who exhibit clinically significant anhedonia and mild depressive symptoms.
✕Probably not a fit
Patients with severe psychiatric conditions, substance abuse issues, or specific contraindications for tDCS may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study investigates the effects of transcranial direct-current stimulation (tDCS) on the brain's reward circuitry in patients with bipolar depression experiencing anhedonia. It aims to determine if tDCS can engage the uncinate fasciculus, a brain tract connecting key regions involved in reward processing, and whether changes in this tract correlate with improvements in anhedonia symptoms. The study will also explore how simulated electric fields may influence these associations. Participants will receive either active or sham tDCS to assess its efficacy.
Why it matters
Potential benefit: If successful, this approach could lead to more effective, personalized treatments for patients suffering from anhedonia associated with bipolar depression.
How similar studies have gone: While the use of tDCS in treating depression has been explored, this specific approach focusing on personalized brain imaging analysis is relatively novel.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * diagnosis of Bipolar Disorder and clinically significant anhedonia * mild symptoms of depression Exclusion Criteria: * substance abuse/dependence and any use of drugs (except alcohol or nicotine) in the previous month of the baseline assessment * participants with personality disorder that would interfere with study participation according to clinical judgment * previous neurological conditions (epilepsy, traumatic brain injury, stroke, etc) * any severe, life-threatening non-psychiatric medical condition * specific contraindications for tDCS (metallic plates in the head) * Participants identified as acutely suicidal or severely agitated
Where it's running
-
The University of Texas Health Science Center at Houston
Houston, Texas, United States Recruiting
Study contacts
- Principal investigator: Jair C Soares, MD,PhD — The University of Texas Health Science Center, Houston
- Study coordinator: Jair C Soares, MD,PhD
- Email: UTMoodDisorders@uth.tmc.edu
- Phone: (713) 486-6663
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Can tACS modulate motivation and reward signals in cannabis use disorder and depression
We’re testing whether a gentle brain stimulation method (tACS) can boost motivation and reward responses in adults with cannabis use and/or depression to see if it helps with anhedonia.
-
iTBS to help anhedonia in depression (dual left DLPFC + OFC or left DLPFC alone)
A brain stimulation study tests whether intermittent theta burst stimulation can help people with major depression who have anhedonia, using both dual-target (left DLPFC and OFC) and single-target (left DLPFC) approaches.
-
How GLP-1 medicines affect happiness and emotional eating in people with obesity
This study follows adults starting GLP-1 weight-loss therapy to see how their feelings of pleasure and emotional eating change over 6 months.
-
Reward Sensitivity Digital App for Adolescent Suicidal Thoughts
A smartphone app is tested in teens to see if daily check-ins and mood-building activities can reduce suicidal thoughts and improve mood.
-
Targeted tACS for anhedonia in older adults with depression
We’re testing personalized transcranial alternating current stimulation (tACS) to see if it improves anhedonia and depressive symptoms in people aged 60 and up with late-life depression.
-
Psilocybin as a New But Simple Test for Residual Anhedonia in Depression
This study tests whether a single 25 mg dose of psilocybin, given with people already on an SSRI or SNRI, can help restore pleasure and motivation in adults with major depressive disorder.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.